株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の分子診断市場:革新・競合・生産性の次のフロンティア - 現在のセグメント予測・サプライヤーのシェア・革新的技術・競合戦略

World Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

発行 Venture Planning Group 商品コード 323049
出版日 ページ情報 英文 1398 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。

Local License: 同一事業所内

Back to Top
世界の分子診断市場:革新・競合・生産性の次のフロンティア - 現在のセグメント予測・サプライヤーのシェア・革新的技術・競合戦略 World Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
出版日: ページ情報: 英文 1398 Pages
概要

当レポートでは、世界の分子診断市場について取り上げ、米国、欧州主要5カ国(フランス、ドイツ、イタリア、スペイン、英国)および日本におけるビジネス・技術動向、5カ年の検査数・売上予測、主要企業の市場シェア、主要アナライザーの機能比較、および革新的技術・製品を開発中の市場参入企業・新興企業のプロファイルなどをまとめ、お届け致します。

第1章 イントロダクション

第2章 世界市場の概要

  • 事業環境
  • 市場構造
  • 市場規模および成長

第3章 主な製品開発機会

  • 装置
  • 試薬キットおよび検査システム/パネル
  • IT
  • 付属機器

第4章 非集中的検査製品の設計基準

第5章 代替の市場浸透戦略

  • 自社開発
  • 提携契約
  • 大学との契約
  • 非集中的検査市場の流通戦略

第6章 潜在的な市場参入障壁およびリスク

  • 市場の成熟
  • コスト上の制約
  • 競合
  • 技術力および限界
  • 特許保護
  • 規制上の制約
  • 非集中的検査市場の課題

第7章 世界市場および技術概要

  • DNAシーケンシング
    • イントロダクション
    • シーケンシング手法
    • オートラジオグラフィー
    • ヒトゲノム解析プロジェクト
    • シーケンシングオートメーション
    • イメージスキャナー
    • 蛍光検出
    • 遺伝子プロファイリング
    • 遺伝子発現
    • 多型スクリーニング
    • タンパク質相互作用ネットワーク
  • DNAおよびRNAプローブ技術
    • 基本原理
    • プローブ調製
    • DNAプローブテスト
    • テスト形式
    • 標識法
    • 増幅法
  • 検出技術
    • 放射性法
    • 非同位体法
  • 分子診断装置のレビュー
    • Abbott LCx
    • Beckman Coulter/Biomek FK
    • Becton Dickinson SDA
    • Bio-Rad GeneScope
    • Gen-Probe Tigris
    • Roche Cobas Amplicor
    • Tecan LS Series and others
  • バイオチップ:遺伝子センサ, マイクロアレイ, およびラボオンチップ
    • 液体輸送および混合
    • 分離
    • 反応
    • 検出
  • ゲノム薬理学
  • 主な用途
    • 微生物学/感染症
    • 癌検査
    • 遺伝性疾患
    • 法医学検査
    • 父子検査/HLAタイピング
    • その他の用途
  • 競合法/補完法
    • モノクローナル抗体/免疫検定法
    • RNAプロ一ブ
    • 二次元電気泳動
    • フローサイトメトリー

第8章 フランスの分子診断市場

  • 事業環境
  • 市場構造
  • 市場規模、検査件数および売上高の予測、主要サプライヤーの売上および市場シェア

第9章 ドイツの分子診断市場

第10章 イタリアの分子診断市場

第11章 日本の分子診断市場

第12章 スペインの分子診断市場

第13章 英国の分子診断市場

第14章 米国の分子診断市場

第15章 競合評価

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Grifols/Novartis
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD20911

This new seven-country study from VPGMarketResearch.com contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

- Business and technological trends in seven major markets:
   France, Germany, Italy, Japan, Spain, UK, and US
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing
   innovative technologies and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market
  segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

- Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer                                - Paternity Testing/HLA Typing
- Genetic Diseases             - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment,
  including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD,
  Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and research centers developing new molecular-
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostics products,
  by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Table of Contents

I. Introduction

II. Worldwide Market Overview

  • 1. Business Environment
  • 2. Market Structure
  • 3. Market Size and Growth

III. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets

VI. Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VII. Worldwide Market And Technology Overview

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA And RNA Probe Technologies
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
    • 4. Test Formats
    • 5. Labeling Techniques
    • 6. Amplification Methods
      • Polymerase Chain Reaction/PCR Variations
      • Strand Displacement Activation
      • TMA
      • Ligase Chain Reaction
      • Branched DNA
        • Hybridization Protection Assay
      • Nucleic-Acid Sequence-Based Amplification
      • Self-Sustained Sequence Replicase
      • Others
        • Ampliprobe
        • CAR
        • CAS
        • CPT
        • Dendritic Polymer Technology
        • ISO-CR
        • LAT
        • Probe Networks
        • RAMP
        • Repair Chain Reaction
        • Rolling Circles
        • Sequence Independent Gene Amplification
        • Sequence Initiation Reaction
        • SISPA
        • Solid Phase Amplification, and others
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
        • P-32
        • S-35
        • H-3
        • I-125
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
        • Indirect Chemical Labeling
        • Direct Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Molecular Diagnostic Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. Becton Dickinson SDA
    • 4. Bio-Rad GeneScope
    • 5. Gen-Probe Tigris
    • 6. Roche Cobas Amplicor
    • 7. Tecan LS Series and others
  • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS
          • Background
          • Diagnostic Tests
          • DNA Probes
            • Overview
            • Quantitative PCR
            • In Situ PCR
            • Needed Improvements
          • Viral Load/Drug Resistance Testing
          • Genotype and Phenotype Testing
          • Blood Banking Considerations
          • Vaccines and Drugs
        • Adenovirus
          • Background
          • Adeno-Associated Viruses (AAV)
          • Diagnostic Tests
          • Vaccines and Drugs
        • Anthrax/Bacillus Anthracis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Babesiosis
          • Background
        • BEA and other Bartonella Diseases
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Chagas Disease
          • Background
        • Campylobacter
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Chlamydia
          • Background
            • Chlamydia psittaci
            • Chlmaydia pneumoniae
            • Chlamydia trachomatis
          • Diagnostic Tests
          • Vaccines and Drugs
        • Creutzfeldt-Jakob's Disease
          • Background
          • Blood Transmission
          • Diagnostic Tests
          • Major Commercial and Academic Players
          • Vaccines and Drugs
        • Cytomegalovirus
          • Background
            • Chorioretinitis
            • Gastrointestinal
            • Central Nervous System Disease
          • Diagnostic Tests
          • Vaccines and Drugs
        • Ebola Virus
          • Background
            • Epidemiology
            • Clinical Syndromes
          • Diagnostic Tests
          • Vaccines and Drugs
        • EchoVirus
          • Background
            • Acute Aseptic Meningitisis
            • Encephalitis
            • Exanthems
            • Respiratory Disease
            • Myopericarditis
            • Neonatal Infections
          • Diagnostic Tests
          • Vaccines and Drugs
        • Encephalitis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Enteroviruses
          • Background
          • Diagnostic Tests
            • Viral Isolation and Identification
            • Antibody Tests
          • Vaccines and Drugs
        • Epstein-Barr Virus
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Gonorrhea
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Hepatitis
          • Hepatitis A
          • Hepatitis B
        • Structure and Composition
        • Replication
          • Hepatitis C
          • Hepatitis D (Delta)
          • Hepatitis E
          • Hepatitis G
          • Hepatitis Infections Pathology
        • Clinical Findings
        • Diagnostics Tests
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D
          • Hepatitis E
        • Virus-Host Immune Reactions
        • Epidemiology
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D (Delta)
        • Vaccines and Drugs
        • Herpes Simplex Virus
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Legionella
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Lyme Disease
          • Background
            • Clinical Description
            • Clinical Case Definition
            • Laboratory Criteria for Diagnosis
            • Case Classification
          • Diagnostic Tests
          • Vaccines and Drugs
        • Malaria
        • Mycoplasma
          • Background
            • Ureaplasma Urealyticum & Mycoplasma
        • Hominis
          • Diagnostic Tests
          • Vaccines and Drugs
        • Papillomaviruses/HPV
          • Background
            • HPV in Cancer
            • Cervical Neoplasm
          • Diagnostic Tests
          • Vaccines and Drugs
            • Prevention
        • Parvovirus B19
          • Background
            • Microbiology
            • Epidemiology
            • Clinical Syndromes
            • Erythema Infectiosum (Slapped Cheek)
            • Adult Polyarthropathy
            • Transient Aplastic Crisis
            • Transient Pancytopenia
            • Red Cell Aplasia in Immunocompromised
            • Perinatal Infections
          • Diagnostic Test
          • Vaccines and Drugs
        • Pneumonia
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Polyomaviruses
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Salmonellosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Shigellosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Streptococci
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
            • Group A Streptococci
            • Group B Streptococci
        • Toxoplasmosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Tuberculosis
          • Background
          • Diagnostic Tests
            • Microscopic Characteristics
            • Cultural Characteristics
            • Skin Tests
            • MDRTB
          • Vaccines and Drugs
        • West Nile Virus
          • Background
            • Clinical Syndromes
          • Diagnostic Tests
          • Vaccines and Drugs
        • Yersinia
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
        • Cancer
        • Cosmetogenomics
        • Cystic Fibrosis
        • Down's Syndrome
        • Duchenne and Becker Muscular Dystrophy
        • Factor V (Leiden)
        • Factor IX Deficiency
        • Fragile X Syndrome
        • Heart Disease
        • Hemochomatosis
        • Hemophilia
        • Huntington's Disease
        • Maternal-Fetal Incompatibility
        • Multiple Endocrine Neoplasia
        • Phenylketonuria (PKU)
        • Polycystic Kidney Disease (PKD)
        • Prenatal Screening
        • Retinitis Pigmentosa
        • Retinoblastoma
        • Sickle Cell Anemia
        • Spinal Muscular Atrophy
        • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
        • Multilocus Probes
        • Single Locus Probes
        • PCR and RFLP
      • c. The FBI
      • d. DNA Profile Data Banks
        • U.S.A.
        • U.K.
      • e. Judicial Implementation
      • f. Major Crime Categories
      • g. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • h. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

VIII. France Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

IX. Germany Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

X. Italy Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XI. Japan Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XII. Spain Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIII. U.K. Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIV. U.S.A. Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XV. Competitive Assessments

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Grifols/Novartis
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

XVI. Appendixes

Appendix I: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

Appendix II: Glossary of Terms

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases
  • Worldwide, Laboratories Performing DNA Sequencing By Country
  • Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
  • Worldwide, Molecular Diagnostic Test Volume Forecast By Country
  • Worldwide, Molecular Diagnostics Market Forecast by Country
  • Summary Table France, Molecular Diagnostic Test Volume And Sales Forecast by Major Application
  • France, Laboratories Performing DNA Sequencing By Market Segment
  • France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • France, Molecular Diagnostic Test Volume Forecast By Major Application
  • France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • France, Infectious Disease Screening NAT Volume Forecast
  • France, Molecular Diagnostics Market Forecast By Major Application
  • France, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • France, Molecular Diagnostics Market By Major Supplier
  • France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
  • Summary Table Germany, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Germany, Molecular Diagnostics Test Volume Forecast By Major Application
  • Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Germany, Infectious Disease Screening NAT Volume Forecast
  • Germany, Molecular Diagnostics Market Forecast By Major Application
  • Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Germany, Molecular Diagnostics Market by Major Supplier
  • Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table Italy, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Italy, Laboratories Performing DNA Sequencing by Market Segment
  • Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Italy, Molecular Diagnostics Test Volume Forecast By Major Application
  • Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Italy, Infectious Disease Screening NAT Volume Forecast
  • Italy, Molecular Diagnostics Market Forecast By Major Application
  • Italy, Infectious Disease Screeningx Nat Reagent Market Forecast by Test
  • Italy, Molecular Diagnostics Market By Major Supplier
  • Italy, HIV/Hepatitis NAT Market By Major Supplier
  • Summary Table Japan, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Japan, Laboratories Performing DNA Sequencing by Market Segment
  • Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Japan, Molecular Diagnostics Test Volume Forecast By Major Application
  • Japan, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Japan, Infectious Disease Screening NAT Volume Forecast
  • Japan, Molecular Diagnostics Market Forecast By Major Application
  • Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Japan, Molecular Diagnostics Market By Major Supplier
  • Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table Spain, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Spain, Laboratories Performing DNA Sequencing by Market Segment
  • Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • Spain, Molecular Diagnostics Test Volume Forecast by Major Application
  • Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Spain, Infectious Disease Screening NAT Volume Forecast
  • Spain, Molecular Diagnostics Market Forecast By Major Application
  • Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Spain, Molecular Diagnostics Market By Major Supplier
  • Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table U.K., Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • U.K., Laboratories Performing Dna Sequencing by Market Segment
  • U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.K., Molecular Diagnostics Test Volume Forecast By Major Application
  • U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.K., Infectious Disease Screening NAT Volume Forecast
  • U.K., Molecular Diagnostics Market Forecast By Major Application
  • U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
  • U.K., Molecular Diagnostics Market by Major Supplier
  • U.K., HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table U.S.A., Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • U.S.A., Laboratories Performing DNA Sequencing by Market Segment
  • U.S.A., Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • U.S.A., Molecular Diagnostics Test Volume Forecast By Major Application
  • U.S.A., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
  • U.S.A., Molecular Diagnostics Market Forecast By Major Application
  • U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
  • U.S.A., Molecular Diagnostics Market by Major Supplier
  • U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
  • U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier
Back to Top